Skip to main content

Madison Avenue Partners, LP

Position in KROS — Keros Therapeutics, Inc.

CIK 1801265 NEW YORK, NY

Position in KROS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,704,438
-$213,038 QoQ
Shares Held
626,583
0.0% QoQ
Ownership
3.16%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#9
of 129 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Madison Avenue Partners, LP holds $266,677,975 across 3 Biotechnology names. KROS ranks #3 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 KROS
Keros Therapeutics, Inc.
This page
626,583 $6,704,438

All Filings in KROS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,704,438 626,583
2026-03-31 $6,917,476 626,583
2025-12-31 $16,770,674 823,707
2025-12-31 $16,770,674 823,707
2025-09-30 $42,844,008 2,708,218
2025-06-30 $35,931,057 2,691,465
2025-05-07 $35,843,451 2,614,402